Press release archive - GSK
New data for Arexvy, GSK’s respiratory syncytial virus vaccine, show potential to help protect a broader group of adults at increased risk for RSV disease.
GSK agrees to settle about 80,000 Zantac lawsuits for up to $2.2
Oct 9, 2024 · GSK has agreed to pay up to $2.2 billion to settle most lawsuits in US state courts claiming that a discontinued version of the heartburn drug Zantac caused cancer, the company announced on...
Press releases | GSK US
New data for AREXVY, GSK’s respiratory syncytial virus vaccine, show potential to help protect a broader group of adults at increased risk for RSV disease.
US FDA approves GSK’s AREXVY, the world’s first respiratory …
May 3, 2023 · The approval is based on data from the positive pivotal AReSVi-006 phase III trial that showed exceptional efficacy in older adults, including those with underlying medical conditions, and in those with severe RSV disease.
GSK plc (GSK) Latest Stock News & Headlines - Yahoo Finance
Get the latest GSK plc (GSK) stock news and headlines to help you in your trading and investing decisions.
FDA Approves GSK's New Blood Cancer Treatment - Bloomberg
Sep 15, 2023 · The US Food and Drug Administration cleared a new treatment from GlaxoSmithKline Plc for a rare blood cancer, bolstering the UK pharmaceutical company’s push back into oncology.
GSK announces independent Consumer Healthcare company is to …
Feb 22, 2022 · GlaxoSmithKline plc (GSK) today announced that the new company, to result from the proposed demerger of Consumer Healthcare from GSK in mid-2022, will be called Haleon.
For media and investors only - GSK
Jun 23, 2021 · At an update to investors today, GlaxoSmithKline plc (GSK LSE & NYSE) will provide details of its strategy, outlook for growth and plans to create shareholder value, following the planned demerger in mid-2022 of its Consumer Healthcare business.
GlaxoSmithKline News | GSK News - NewsNow
NewsNow aims to be the world's most accurate and comprehensive aggregator of GlaxoSmithKline news, covering the latest share price, company announcements, vaccine trials, product news and more from the best online publications.
GSK Reveals Provisional 2025 Dividend Schedule - Nasdaq
2 days ago · GSK Reveals Provisional 2025 Dividend Schedule. November 11, 2024 — 10:07 am EST. Written by TipRanks UK Auto-Generated Newsdesk for TipRanks ->. GlaxoSmithKline (GB:GSK) has released an update ...